Alzheimer’s disease is a type of brain disorder that causes damage to nerve cells, affecting memory, language, and thinking.
Symptoms usually begin subtly and may appear up to 20 years before clinical detection.

It is the 6th leading cause of death in the United States (2019) and affects more than 55 million people worldwide (2021).
The disease primarily occurs in individuals over 65 years old, progresses slowly but becomes increasingly severe, significantly impacting the lives of patients and caregivers.

The main causes include the accumulation of beta-amyloid and tau proteins, leading to the degeneration of nerve cells.
Currently, there is no complete cure, but early diagnosis and proper treatment can help slow disease progression.

New tools such as the One Step Dementia Risk Test Kit support screening and risk assessment of dementia through biological markers (amyloid-β3 protein), helping physicians monitor and intervene early.